In conclusion, we can assume it’s another COVID-19 variant to talk about. People first mentioned it in Maharashtra, India on 5 October 2020. This COVID-19 strain is about to become dominant in the UK in a few days. Briefly, it has 3 sub-lineages, each with totally different mutations. WHO defined it as a variant of concern on 11th May, UK labeled B.617.2 on 6 May. Despite consecutive numbers, B.1.617.3 was spotted in October. B.1.617.1 and B.1.617.2 emerged later in December. By transmissibility it’s close to B.1.1.7 and scientists refer to it as a double mutant. The name goes after its nature of gene encoding. The SARS-CoV-2 spike protein it contains presents 2 mutations altogether causing the substitutions E484Q and L452R.
Sharing common concerns, Downing Street called a press conference on Friday 14 May. It then expanded measures for people over 50 and the clinically vulnerable to 8 weeks after the first dose, up from 12. People over 40 are also prioritised for a first dose. Officials sent a rapid response team of 100 nurses, public health advisers and environmental health officers. Johnson said the army will be set on the streets of Blackburn and Bolton, equipped with COVID-19 tests. Due to the emergency, the vaccination centres will also work with extended hours. However, finite supply of doses makes it hard to pursue a local surge vaccination.
For India, the situation escalates and gets worse. They intensively experience 2 COVID-19 wave and red light is signaling out of control. The deadly Indian variant hits back in the UK, more fierce and threatening to rule over the country. Some suggestions speculate this could be now turning into an even bigger global crisis. Whether true or false, only time will tell. Gradually, we spent too much on believing fake news that never happened.
MVS Pharma GmbH is an innovative pharmaceutical start-up company, which researches in the area of reducing viruses and bacteria with plant based aerosols. Their special formula ensures the purity and the stability of the used ingredients during storage.
Liliya Ganeva is an article writer, who explores all the actual, up-to-date COVID-19 information, and the possibilities for producing aerosols made out of plants against respiratory viruses and bacteria.